Regeneron Stock Slumps After FDA Decision Delays Blockbuster Release
The Food and Drug Administration rejected its application for approval of a new, higher-dose version of eye disease treatment Eylea.
Source: marketwatch.com
Stay updated with breaking news from Ch Rog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration rejected its application for approval of a new, higher-dose version of eye disease treatment Eylea.